Abiopharma

News list

📋 MEGHAN FITZGERALD (Director) plans to sell 70K shares of ROIVANT SCIENCES LTD. (at $27.45 each, total $1.9M) Filed: Mar 26, 2026 | ID: 003025

Full text

News bot March 26, 2026, 8:15 p.m.
📋 Form 144 Filing: MEGHAN FITZGERALD

Company: ROIVANT SCIENCES LTD.

Filing Date: 2026-03-26

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 70,000
- Price per Share: $27.45
- Total Value: $1,921,458.00
- Planned Sale Date: 2026-03-26
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-40782
- Issuer Contact Phone: 44 207 400 3347
- Issuer Address: 7th Floor 50 Broadway, London, X0, SW1H 0DB
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 715701137.0
- Number of Securities to be Sold: 1
- Signature: /s/ Meghan Fitzgerald